Basit öğe kaydını göster

dc.contributor.authorÖzşeker, Burak
dc.contributor.authorŞahin, Cem
dc.contributor.authorSolak Özşeker, Havva
dc.contributor.authorEfe, S. Cumali
dc.contributor.authorKav, Taylan
dc.contributor.authorBayraktar, Yusuf
dc.date.accessioned2020-11-20T15:03:20Z
dc.date.available2020-11-20T15:03:20Z
dc.date.issued2016
dc.identifier.issn0278-0240
dc.identifier.issn1875-8630
dc.identifier.urihttps://doi.org/10.1155/2016/5423043
dc.identifier.urihttps://hdl.handle.net/20.500.12809/2707
dc.descriptionWOS: 000382630600001en_US
dc.descriptionPubMed ID: 27642216en_US
dc.description.abstractOne of the regions of involvement of Behc, et's disease (BD), a systematic inflammatory vasculitis with unknown etiology, is the gastrointestinal (GI) tract. Upper GI endoscopy, colonoscopy, and capsule endoscopy are frequently used methods to diagnose the intestinal involvement of BD. The aim of this study was to investigate the role of fecal calprotectin (FC) in the evaluation of intestinal involvement in BD. Material and Method. A total of 30 patients who were diagnosed with BD and had no GI symptoms and 25 individuals in the control group were included in this study. Results. Levels of FC were statistically significantly higher in patients with BD compared to the control group (p < 0.001). The correlation analysis performed including FC and markers of disease activity revealed a positive and statistically significant correlation between FC level and CRP and erythrocyte sedimentation rate (r : 0.255, p < 0.049, and r : 0.404, p < 0.001, resp.). FC levels in patients who were detected to have ulcers in the terminal ileum and colon in the colonoscopic examination were statistically significantly higher compared to the patients with BD without intestinal involvement (p = 0.01). Conclusion. The measurement of FC levels, in patients with BD who are asymptomatic for GI involvement, may be helpful to detect the possible underlying intestinal involvement.en_US
dc.item-language.isoengen_US
dc.publisherHindawi Ltden_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBehcet's Diseaseen_US
dc.titleThe Role of Fecal Calprotectin in Evaluating Intestinal Involvement of Behcet's Diseaseen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorÖzşeker, Burak
dc.contributor.institutionauthorŞahin, Cem
dc.contributor.institutionauthorSolak Özşeker, Havva
dc.identifier.doi10.1155/2016/5423043
dc.relation.journalDisease Markersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster